Wednesday, April 07, 2021 12:06:22 PM
More content below
LFMD
-0.75%
LifeMD, Inc.
Wed, April 7, 2021, 8:31 AM
More content below
LFMD
-0.75%
The brand launch into tele-dermatology adds further portfolio diversification into exciting and fast-growing area of patient healthcare
NEW YORK, April 07, 2021 (GLOBE NEWSWIRE) -- LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the successful launch of NavaMD™. The NavaMD website went live at the end of the first quarter of fiscal 2021 and is the Company’s personalized tele-dermatology brand and clinic, offering services to patients across all 50 states.
Justin Schreiber, Chairman and CEO commented, “We are pleased to bring the NavaMD brand to life in 2021, as this will be LifeMD’s third successful brand launch in four years. We are an early mover in the $40 billion-dollar high growth direct-to-patient tele-dermatology space and are well-positioned to grow market share. By empowering patients seeking telehealth services, we feel that LifeMD is best positioned to actively bring about a sea change in both the convenience and accessibility by which patients receive personalized services and medications when needed. As such, we remain focused on refining customer acquisition strategies and building a de-risked brand portfolio that addresses low risk, massively underpenetrated and addressable markets such as the NavaMD clinical skincare offering.”
“By focusing on fast growing, therapeutic areas with high unmet needs, whose treatments are proven to be safe, we are creating the best runway for unrivaled growth in telehealth customer acquisition, recurring revenues and return on shareholder value,” mentioned Stefan Galluppi, Chief Technology Officer.
NavaMD’s services will be available to any patient seeking dermatology services. Service offerings include the diagnosis and treatment of prevalent skin conditions such as acne, rosacea, hyperpigmentation, signs of aging, and other prevalent skin conditions. NavaMD’s customer acquisition strategy will be primarily set to growing its female customer base, fully supported by best-in-class direct response marketing, social media, and influencer campaigns. Online medical treatment and services will be rendered through LifeMD’s network of U.S. licensed physicians, pharmacies, and, if appropriate, prescription oral and compounded topical medications to treat many common dermatological conditions. In addition to the brand’s telemedicine offerings, NavaMD’s proprietary products leverage intellectual property and proprietary formulations licensed from Restorsea, a leading medical grade skincare technology platform. NavaMD is the first external provider to offer Restorsea’s patented medical-grade over-the-counter products for treating these prevalent skin conditions.
Like other LifeMD brands, NavaMD tele-dermatology services is highly personalized, powered by a proprietary technology stack. The engagement with patients is seamless and is driven by a simple three-step customer journey consisting of:
Completing a free consultation: whereby a questionnaire and patient photo is submitted for review.
Getting prescribed a custom formulated treatment regimen: NavaMD’s licensed U.S. doctors, and clinicians then work to design a custom prescription skincare treatment. A quick and convenient checkout process powered by LifeMD’s telehealth platform fills a prescription.
The patient receives a personalized treatment by mail: LifeMD’s pharmacy services prepares and delivers a customer’s custom prescription treatment on a monthly recurring basis or as often as needed.
About LifeMD
Recent LFMD News
- LifeMD Becomes the First Virtual Primary Care Provider to Elevate GLP-1 Patient Care with Real-time, At-Home Monitoring of Blood Pressure and Body Composition • GlobeNewswire Inc. • 05/02/2024 12:00:00 PM
- LifeMD Appoints Dr. Calum MacRae to its Board of Directors • GlobeNewswire Inc. • 04/29/2024 12:00:00 PM
- LifeMD to Report First Quarter 2024 Financial Results on May 8 • GlobeNewswire Inc. • 04/24/2024 12:00:00 PM
- LifeMD to Participate in Upcoming Investor and Industry Conferences During May • GlobeNewswire Inc. • 04/23/2024 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 03/26/2024 12:00:00 PM
- LifeMD to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/25/2024 12:00:00 PM
- LifeMD Reports Fourth Quarter 2023 Results • GlobeNewswire Inc. • 03/11/2024 08:05:00 PM
- U.S. Index Futures Dip Ahead of Inflation Data and Oracle’s Earnings; Oil Prices Edge Higher • IH Market News • 03/11/2024 10:39:47 AM
- LifeMD to Report Fourth Quarter 2023 Financial Results on March 11 • GlobeNewswire Inc. • 02/26/2024 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Webinar • GlobeNewswire Inc. • 02/15/2024 01:00:00 PM
- LifeMD to Participate in the 11th Annual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference • GlobeNewswire Inc. • 01/31/2024 01:00:00 PM
- Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET • GlobeNewswire Inc. • 01/22/2024 09:15:00 PM
- LifeMD to Participate in the Maxim Group 2024 Healthcare IT Virtual Conference • GlobeNewswire Inc. • 01/18/2024 01:00:00 PM
- LifeMD Provides 2024 Financial Guidance • GlobeNewswire Inc. • 01/08/2024 01:00:00 PM
- WeightWatchers Stock Drops 12% After Eli Lilly Launches DTC Weight-Loss Drug Service • Dow Jones News • 01/04/2024 09:30:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 12/26/2023 09:05:00 PM
- LifeMD and Medifast Partner to Offer Transformative Weight Management Solution • GlobeNewswire Inc. • 12/13/2023 11:00:00 AM
- LifeMD Executives to Participate in RWJBarnabas Health’s Telehealth Symposium • GlobeNewswire Inc. • 12/07/2023 01:00:00 PM
- LifeMD to Participate in Upcoming Investor Conferences and Panel Discussions • GlobeNewswire Inc. • 11/10/2023 01:00:00 PM
- LifeMD Reports Third Quarter 2023 Results; Record Revenue and Adjusted EBITDA • GlobeNewswire Inc. • 11/08/2023 09:05:00 PM
- LifeMD Ranked Number 166 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™ • GlobeNewswire Inc. • 11/08/2023 01:00:00 PM
- LifeMD to Report Third Quarter 2023 Financial Results on November 8 • GlobeNewswire Inc. • 10/25/2023 12:00:00 PM
- Particle Health and LifeMD Demonstrate the Potential of Using Comprehensive Electronic Health Record Data to Triage Patients for GLP-1 Weight Management Therapy • GlobeNewswire Inc. • 10/03/2023 10:00:00 AM
- LifeMD to Participate in Two Investor Conferences in October • GlobeNewswire Inc. • 09/27/2023 12:00:00 PM
- LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock • GlobeNewswire Inc. • 09/26/2023 12:00:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM